Persephone Borrow

Active 1991–2024

94
Papers
21,102
Citations
71
h-index
92
i10-index

Citations

Citations per year for Persephone Borrow1988: 5 citations1990: 2 citations1991: 2 citations1992: 2 citations1993: 5 citations1994: 5 citations1995: 32 citations1996: 43 citations1997: 113 citations1998: 152 citations1999: 143 citations2000: 180 citations2001: 167 citations2002: 173 citations2003: 152 citations2004: 234 citations2005: 208 citations2006: 219 citations2007: 185 citations2008: 182 citations2009: 168 citations2010: 204 citations2011: 220 citations2012: 208 citations2013: 166 citations2014: 130 citations2015: 154 citations2016: 163 citations2017: 131 citations2018: 123 citations2019: 442 citations2020: 529 citations2021: 708 citations2022: 476 citations2023: 318 citations2024: 408 citations2025: 175 citations2026: 3 citations1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,195 citing papers, 35.7% of this breakdownUnited Kingdom: 917 citing papers, 10.3% of this breakdownGermany: 510 citing papers, 5.7% of this breakdownChina: 496 citing papers, 5.5% of this breakdownFrance: 402 citing papers, 4.5% of this breakdownCanada: 337 citing papers, 3.8% of this breakdownAustralia: 328 citing papers, 3.7% of this breakdownSwitzerland: 250 citing papers, 2.8% of this breakdownItaly: 244 citing papers, 2.7% of this breakdownJapan: 218 citing papers, 2.4% of this breakdownNetherlands: 210 citing papers, 2.3% of this breakdownSouth Africa: 157 citing papers, 1.8% of this breakdown
0%35.7%Other 18.8%

Fields

  • Immunology and Microbiology53.5%
  • Medicine34.1%
  • Biochemistry, Genetics and Molecular Biology9%
  • Neuroscience1.3%
  • Agricultural and Biological Sciences1%
  • Environmental Science0.2%
  • Other0.9%

Topics

  • Immune Cell Function and Interaction11.6%
  • HIV Research and Treatment8.8%
  • T-cell and B-cell Immunology7.7%
  • Immunotherapy and Immune Responses7.1%
  • SARS-CoV-2 and COVID-19 Research4.6%
  • interferon and immune responses3.3%
  • Other56.9%

Coauthors

All papers

Open in search
  1. Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies

    Authors: , , , , , , , , , , - Nature reviews. Immunology 2022 cited by 361

  2. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dannielle Wellington, Ushani Rajapaksa, Yi‐Ling Chen, Mariolina Salio, Giorgio Napolitani, Wayne Paes, Persephone Borrow, Benedikt M. Kessler, Jeremy Fry, Nikolai F. Schwabe, Malcolm G. Semple, J. Kenneth Baillie, Shona C. Moore, Peter Openshaw, M. Azim Ansari, Susanna Dunachie, Eleanor Barnes, John Frater, Georgina Kerr, Philip Goulder, Teresa Lockett, Robert H. Levin, Yonghong Zhang, Ronghua Jing, Ling‐Pei Ho, Eleanor Barnes, Danning Dong, Tao Dong, Susanna Dunachie, John Frater, Philip Goulder, Georgina Kerr, Paul Klenerman, Guihai Liu, Andrew J. McMichael, Giorgio Napolitani, Graham S. Ogg, Yanchun Peng, Mariolina Salio, Xuan Yao, Zixi Yin, ISARIC4C Investigators, J. Kenneth Baillie, Paul Klenerman, Alexander J. Mentzer, Shona C. Moore, Peter Openshaw, Malcolm G. Semple, David I. Stuart, Lance Turtle, Richard J. Cornall, Christopher P. Conlon, Paul Klenerman, Gavin Screaton, Juthathip Mongkolsapaya, Andrew J. McMichael, Julian C. Knight, Graham S. Ogg, Tao Dong - Nature Immunology 2020 cited by 1,372

  3. Viruses transfer the antiviral second messenger cGAMP between cells

    Authors: , , , , , , , , , - Science 2015 cited by 244

  4. Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo

    Authors: , , - Science 1996 cited by 1,082

  5. Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

    Authors: , , , , , , , , , , , - Journal of Virology 2009 cited by 751

  6. Type I interferons produced by dendritic cells promote their phenotypic and functional activation

    Authors: , , , , , , - Blood 2002 cited by 532

  7. Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors

    Authors: , , , , , , , , , , , , , , , , , , , - Cell Reports Medicine 2021 cited by 62

  8. Identification of α-Dystroglycan as a Receptor for Lymphocytic Choriomeningitis Virus and Lassa Fever Virus

    Authors: , , , , , , , , , - Science 1998 cited by 711

  9. CD4+ T Follicular Helper Cells in Human Tonsils and Blood Are Clonally Convergent but Divergent from Non-Tfh CD4+ Cells

    Authors: , , , , , , , , , , , , , - Cell Reports 2020 cited by 121

  10. The immune response during acute HIV-1 infection: clues for vaccine development

    Authors: , , , , - Nature reviews. Immunology 2009 cited by 847

  11. Phenotypic properties of transmitted founder HIV-1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George M. Shaw, Beatrice H. Hahn - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 438

  12. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

    Authors: , , , , , , , - Nature Immunology 2003 cited by 791

  13. Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction

    Authors: , , , , , , , , , , - Cell Host & Microbe 2016 cited by 181

  14. Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2018 cited by 116

  15. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage

    Authors: , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2007 cited by 418

  16. Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George M. Shaw, Persephone Borrow, Katharine J. Bar, Beatrice H. Hahn - Science Translational Medicine 2021 cited by 83

  17. Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 84

  18. HLA-E–restricted, Gag-specific CD8 + T cells can suppress HIV-1 infection, offering vaccine opportunities

    Authors: , , , , , , , , , , , , , , , , , , - Science Immunology 2021 cited by 60

  19. Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity

    Authors: , , , , , , , , , , , , , , , , , , , , , , - British Journal of Cancer 2020 cited by 59

  20. Intracellular trafficking of HLA-E and its regulation

    Authors: , , , , , , , - The Journal of Experimental Medicine 2023 cited by 43

  21. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2009 cited by 643

  22. Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases

    Authors: , , , , , , , , , , , , - Journal of Virology 2017 cited by 125

  23. Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections

    Authors: , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 105

  24. Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth

    Authors: , , , , , , , , , , , , , - Nature Immunology 2020 cited by 85